{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:11:13Z","timestamp":1769166673368,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T00:00:00Z","timestamp":1343001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0041289","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T22:10:49Z","timestamp":1343081449000},"page":"e41289","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case\/Non-Case Approach"],"prefix":"10.1371","volume":"7","author":[{"given":"Hilda J. I.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti R. F.","family":"Saldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf H.","family":"Klungel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob J.","family":"Vandebriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"Souverein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald H. B.","family":"Meyboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L. M. (Anneke)","family":"Passier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"van Loveren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Willem Cohen","family":"Tervaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,7,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.","volume":"366","author":"C Baigent","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tcm.2005.07.002","article-title":"Toward immunomodulatory and anti-inflammatory properties of statins.","volume":"15","author":"C Arnaud","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial.","volume":"373","author":"PM Ridker","year":"2009","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2011.155622","article-title":"Use of statins is associated with an increased risk of rheumatoid arthritis.","volume":"71","author":"HJ De Jong","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: A systematic review.","volume":"21","author":"B Noel","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism.","volume":"8","author":"BA Golomb","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref7","first-page":"S75","article-title":"A case of ANCA-associated systemic vasculitis induced by atorvastatin.","author":"M Haroon","year":"2008"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/j.1756-185X.2010.01481.x","article-title":"ANCA-positive vasculitis associated with simvastatin\/ezetimibe: Expanding the spectrum of statin-induced autoimmunity?","volume":"13","author":"D Sen","year":"2010","journal-title":"International Journal of Rheumatic Diseases"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10067-003-0772-8","article-title":"Cerivastatin-induced polymyalgia rheumatica-like illness.","volume":"23","author":"V Go\u00ebb","year":"2004","journal-title":"Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMcpc059040","article-title":"Case records of the massachusetts general hospital. case 4\u20132006. A 79-year-old woman with myalgias, fatigue, and shortness of breath.","volume":"354","author":"J Kay","year":"2006","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00005792-199811000-00002","article-title":"Systemic immune reactions to HMG-CoA reductase inhibitors. report of 4 cases and review of the literature.","volume":"77","author":"L Rudski","year":"1998","journal-title":"Medicine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2011.06.002","article-title":"Association between statin use and lupus-like syndrome using spontaneous reports.","volume":"41","author":"HJ De Jong","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/rheumatology\/41.12.1455","article-title":"A fresh look at polymyalgia rheumatica.","volume":"41","author":"A Samanta","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis.","volume":"347","author":"C Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/009286150804200501","article-title":"Vigibase, the WHO global ICSR database system: Basic facts.","volume":"42","author":"M Lindquist","year":"2008","journal-title":"Drug Inf J"},{"key":"ref16","article-title":"Guidelines for ATC classification and DDD assigment.","year":"1999"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/BOR.0b013e32832f13db","article-title":"Drug-induced autoimmunity.","volume":"21","author":"F Dedeoglu","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/oxfordjournals.aje.a114131","article-title":"Confounding and misclassification.","volume":"122","author":"S Greenland","year":"1985","journal-title":"Am J Epidemiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: A 10-year epidemiologic and clinical study.","volume":"97","author":"TY Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: Evidence for synovitis.","volume":"13","author":"LA Healey","year":"1984","journal-title":"Semin Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","article-title":"Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the united kingdom, 1990\u20132001.","volume":"65","author":"L Smeeth","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in olmsted county, minnesota, 1970\u20131991.","volume":"38","author":"C Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref23","first-page":"205","article-title":"The under-reporting of adverse drug reactions in general practice.","volume":"1","author":"CE Lumley","year":"1986","journal-title":"Pharmaceut Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/bmj.317.7151.119","article-title":"Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: Observational study.","volume":"317","author":"RM Martin","year":"1998","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2010.11.039","article-title":"The relationship of vitamin D deficiency to statin myopathy.","volume":"215","author":"A Gupta","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/SMJ.0b013e3181e21088","article-title":"Resolution of statin-induced myalgias by correcting vitamin D deficiency.","volume":"103","author":"DS Bell","year":"2010","journal-title":"South Med J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2265.2008.03448.x","article-title":"Vitamin D insufficiency\u2013a novel mechanism of statin-induced myalgia?","volume":"71","author":"P Lee","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trsl.2008.11.002","article-title":"Low serum 25 (OH) vitamin D levels (<32 ng\/mL) are associated with reversible myositis-myalgia in statin-treated patients.","volume":"153","author":"W Ahmed","year":"2009","journal-title":"Transl Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S470","DOI":"10.1161\/circ.118.suppl_18.S_470","article-title":"Abstract 3701: Vitamin D deficiency is associated with myalgias in hyperlipidemic subjects taking statins.","volume":"118","author":"PB Duell","year":"2008","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.autrev.2011.05.002","article-title":"Effects of vitamin D on the peripheral adaptive immune system: A review.","volume":"10","author":"E Peelen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e15235","DOI":"10.1371\/journal.pone.0015235","article-title":"Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.","volume":"5","author":"J Smolders","year":"2010","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica.","volume":"49","author":"B Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels.","volume":"137","author":"P Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins.","volume":"41","author":"P Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.","volume":"62","author":"L Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2125.2003.01968.x","article-title":"Application of data mining techniques in pharmacovigilance.","volume":"57","author":"AM Wilson","year":"2004","journal-title":"Br J Clin Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0041289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T19:48:51Z","timestamp":1642880931000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0041289"}},"subtitle":[],"editor":[{"given":"Joel Joseph","family":"Gagnier","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,23]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0041289","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,23]]}}}